MiR-125b inhibits tumor growth and promotes apoptosis of cervical cancer cells by targeting phosphoinositide 3-kinase catalytic subunit delta

Cellular Physiology and Biochemistry

Volumn 30, Issue 5, 2012, Pages 1310-1318

  Cui, Fang ^a   Li, Xiuli ^b   Zhu, Xiangyu ^a   Huang, Lili ^a   Huang, Yongfang ^a   Mao, Caiying ^a   Yan, Qi ^a   Zhu, Jianhong ^a   Zhao, Wenxia ^a   Shi, Hong ^a  

^a Department of Urology Shanghai Jiangwan Hospital   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Apoptosis; Cervical cancer; HeLa; Phosphoinositide 3 kinase catalytic subunit delta; Post transcriptional regulation

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA 125B; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOINOSITIDE 3 KINASE CATALYTIC SUBUNIT DELTA; PROTEIN BID; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; GENE OVEREXPRESSION; HELA CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION; UTERINE CERVIX CANCER;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HELA CELLS; HUMANS; MICRORNAS; PHOSPHATIDYLINOSITOL 3-KINASES; STRUCTURE-ACTIVITY RELATIONSHIP; UTERINE CERVICAL NEOPLASMS;

EID: 84873124028     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000343320     Document Type: Article

References (33)

1. Ambros V: The functions of animal micrornas. Nature 2004;431:350-355. (Pubitemid 39265675)
2. Miska EA: How micrornas control cell division, differentiation and death. Curr Opin Genet Dev 2005;15:563-568. (Pubitemid 41262414)
3. Calin GA, Croce CM: Microrna signatures in human cancers. Nat Rev Cancer 2006;6:857-866. (Pubitemid 44629897)
4. Johnson CD, Esquela-Kerscher A, Stefani G, Byrom M, Kelnar K, Ovcharenko D, Wilson M, Wang X, Shelton J, Shingara J, Chin L, Brown D, Slack FJ: The let-7 microrna represses cell proliferation pathways in human cells. Cancer Res 2007;67:7713-7722. (Pubitemid 47281364)
5. Kent OA, Mendell JT: A small piece in the cancer puzzle: Micrornas as tumor suppressors and oncogenes. Oncogene 2006;25:6188-6196. (Pubitemid 44527849)
6. Hu X, Schwarz JK, Lewis JS, Jr., Huettner PC, Rader JS, Deasy JO, Grigsby PW, Wang X: Reduced mir-100 expression in cervical cancer and precursors and its carcinogenic effect through targeting plk1 protein 2011. Cancer Res 2011;70:1441-1448.
7. Lee JW, Choi CH, Choi JJ, Park YA, Kim SJ, Hwang SY, Kim WY, Kim TJ, Lee JH, Kim BG, Bae DS: Altered microrna expression in cervical carcinomas. Clin Cancer Res 2008;14:2535-2542.
8. Lui WO, Pourmand N, Patterson BK, Fire A: Patterns of known and novel small rnas in human cervical cancer. Cancer Res 2007;67:6031-6043. (Pubitemid 47037482)
9. Martinez I, Gardiner AS, Board KF, Monzon FA, Edwards RP, Khan SA: Human papillomavirus type 16 reduces the expression of microrna-218 in cervical carcinoma cells. Oncogene 2008;27:2575-2582. (Pubitemid 351550884)
10. Muralidhar B, Goldstein LD, Ng G, Winder DM, Palmer RD, Gooding EL, Barbosa-Morais NL, Mukherjee G, Thorne NP, Roberts I, Pett MR, Coleman N: Global microrna profiles in cervical squamous cell carcinoma depend on drosha expression levels. J Pathol 2007;212:368-377. (Pubitemid 47099013)
11. Pett MR, Herdman MT, Palmer RD, Yeo GS, Shivji MK, Stanley MA, Coleman N: Selection of cervical keratinocytes containing integrated hpv16 associates with episome loss and an endogenous antiviral response. Proc Natl Acad Sci U S A 2006;103:3822-3827. (Pubitemid 43376639)
12. Wang X, Tang S, Le SY, Lu R, Rader JS, Meyers C, Zheng ZM: Aberrant expression of oncogenic and tumorsuppressive micrornas in cervical cancer is required for cancer cell growth. PLoS One 2008;3:e2557.
13. Zhao A, Zeng Q, Xie X, Zhou J, Yue W, Li Y, Pei X: Microrna-125b induces cancer cell apoptosis through suppression of bcl-2 expression. J Genet Genomics 2012;39:29-35.
14. Liu L, Yu X, Guo X, Tian Z, Su M, Long Y, Huang C, Zhou F, Liu M, Wu X, Wang X: Mir-143 is downregulated in cervical cancer and promotes apoptosis and inhibits tumor formation by targeting bcl-2. Mol Med Report 2012;5:753-760.
15. Qiang R, Wang F, Shi LY, Liu M, Chen S, Wan HY, Li YX, Li X, Gao SY, Sun BC, Tang H: Plexin-b1 is a target of mir-214 in cervical cancer and promotes the growth and invasion of hela cells. Int J Biochem Cell Biol 2011;43:632-641.
16. Wang F, Li Y, Zhou J, Xu J, Peng C, Ye F, Shen Y, Lu W, Wan X, Xie X: Mir-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor sp1. Am J Pathol 2011;179:2580-2588.
17. Xu J, Li Y, Wang F, Wang X, Cheng B, Ye F, Xie X, Zhou C, Lu W: Suppressed mir-424 expression via upregulation of target gene chk1 contributes to the progression of cervical cancer. Oncogene 2012; doi: 10.1038/onc.2012.121.
18. Li BH, Zhou JS, Ye F, Cheng XD, Zhou CY, Lu WG, Xie X: Reduced mir-100 expression in cervical cancer and precursors and its carcinogenic effect through targeting plk1 protein. Eur J Cancer 2011 47:2166-2174.
19. Shi L, Zhang S, Feng K, Wu F, Wan Y, Wang Z, Zhang J, Wang Y, Yan W, Fu Z, You Y: Microrna-125b-2 confers human glioblastoma stem cells resistance to temozolomide through the mitochondrial pathway of apoptosis. Int J Oncol 2011;40:119-129.
20. Wilting SM, Snijders PJ, Verlaat W, Jaspers A, Van De Wiel MA, Van Wieringen WN, Meijer GA, Kenter GG, Yi Y, Le Sage C, Agami R, Meijer CJ, Steenbergen RD: Altered microrna expression associated with chromosomal changes contributes to cervical carcinogenesis. Oncogene 2012; doi: 10.1038/onc.2012.20.
21. Li BH, Zhou JS, Ye F, Cheng XD, Zhou CY, Lu WG, Xie X: Reduced mir-100 expression in cervical cancer and precursors and its carcinogenic effect through targeting plk1 protein Eur J Cancer 2011;47:2166-2174.
22. Alpini G, Glaser SS, Zhang JP, Francis H, Han Y, Gong J, Stokes A, Francis T, Hughart N, Hubble L, Zhuang SM, Meng F: Regulation of placenta growth factor by microrna-125b in hepatocellular cancer. J Hepatol 2011;55:1339-1345.
23. Tang F, Zhang R, He Y, Zou M, Guo L, Xi T: Microrna-125b induces metastasis by targeting stard13 in mcf-7 and mda-mb-231 breast cancer cells. PLoS One 2012;7:e35435.
24. Xia HF, He TZ, Liu CM, Cui Y, Song PP, Jin XH, Ma X: Mir-125b expression affects the proliferation and apoptosis of human glioma cells by targeting bmf. Cell Physiol Biochem 2009;23:347-358.
25. Bartel DP: Micrornas: Genomics, biogenesis, mechanism, and function. Cell 2004;116:281-297.
26. Lewis B P, Burge CB, Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microrna targets. Cell 2005;120:15-20. (Pubitemid 40094598)
27. Karlidag T, Cobanoglu B, Keles E, Alpay HC, Ozercan I, Kaygusuz I, Yalcin S, Sakallioglu O: Expression of bax, p53, and p27/kip in patients with papillary thyroid carcinoma with or without cervical nodal metastasis. Am J Otolaryngol 2007;28:31-36. (Pubitemid 44879656)
28. Jay C, Nemunaitis J, Chen P, Fulgham P, Tong AW: Mirna profiling for diagnosis and prognosis of human cancer. DNA Cell Biol 2007;26:293-300. (Pubitemid 46799178)
29. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM: Human microrna genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 2004;101:2999-3004. (Pubitemid 38327724)
30. Zhang L, Huang J, Yang N, Greshock J, Megraw MS, Giannakakis A, Liang S, Naylor TL, Barchetti A, Ward MR, Yao G, Medina A, O'Brien-Jenkins A, Katsaros D, Hatzigeorgiou A, Gimotty PA, Weber BL, Coukos G: Micrornas exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA 2006;103:9136-9141. (Pubitemid 43902545)
31. Yao Q, Xu H, Zhang QQ, Zhou H, Qu LH: Microrna-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (pdcd4) in hela cervical carcinoma cells. Biochem Biophys Res Commun 2009;388:539-542.
32. Peng RQ, Wan HY, Li HF, Liu M, Li X, Tang H: Microrna-214 suppresses growth and invasiveness of cervical cancer cells by targeting udp-n-acetyl-alpha-d-galactosamine: Polypeptide n- acetylgalactosaminyltransferase 7. J Biol Chem 2012;287:14301-14309.
33. Wang H, Tan G, Dong L, Cheng L, Li K, Wang Z, Luo H: Circulating mir-125b as a marker predicting chemoresistance in breast cancer. PLoS One 2012;7:e34210.